Synlett 1992; 1992(6): 537-538
DOI: 10.1055/s-1992-21408
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Stereoselective Synthesis of the Cytotoxic Acetogenins (+)- and (-)-Muricatacin

James A. Marshall* , Gregory S. Welmaker
  • *Department of Chemistry and Biochemistry, The University of South Carolina, Columbia, South Carolina 29208, USA
Further Information

Publication History

Publication Date:
08 March 2002 (online)

Reduction of 2-tridecenoyl(tributyl)stannane (2) with (S)- or (R)-BINAL-H [lithium (1,1′-binaphthalene-2,2′-diolato)-(ethanolato)hydridoaluminate] followed by silylation and 1,3-isomerization afforded the γ-silyloxy allylstannanes (R)-5 and (S)-5, respectively, of ca. 95% ee. The former yielded the hydroxy ester (S,S)-8 of 95% ee upon addition to ethyl 3-formyl-2-propenoate (7) in the presence of diethyl ether-boron trifluoride complex. The enantiomer (R,R)-8 was likewise secured from 7 and (S)-5. Hydrogenation then tert-butyldimethylsilyl cleavage with hydrogen fluoride led directly to (+)-muricatacin (S,S-11) [(S,S)-5-hydroxy-4-heptadecanolide] from (S,S)-8 and (-)-muricatacin (R,R-11) from (R,R)-8.